
Archiv der Pharmazie p. 383 - 386 (1997)
Update date:2022-09-26
Topics:
Catarzi, Daniela
Colotta, Vittoria
Varano, Flavia
Cecchi, Lucia
Filacchioni, Guido
Galli, Alessandro
Costagli, Chiara
Some pyrazolo[3,4-c]quinoline-4-ones 1-14 and pyrazolo[3,4-c]-quinoline-1,4-diones 15-17 were prepared and biologically evaluated for their binding at the benzodiazepine receptor (BZR) in rat cortical membranes. The moderate binding activity of 1-5, 7, 9-10, 13 is attributable to the lack of the optional proton acceptor at position-1, while the inactivity of the 1,4-dione derivatives 15-17 is due to the lack of the essential proton acceptor at position-3. These conclusions confirm the validity of our proposed pharmacophoric model.
View MoreShaanxi Sinuote Biotech Co.,Ltd
Contact:+86-29-68859685
Address:No 18,Taiyuan Road ,Xi'an city ,China
Changzhou Kingyo Chemical Corporation Ltd.
website:http://www.kingyochem.com
Contact:+86-519-85105717
Address:19# Wuqing North Road, Changzhou , Jiangsu, China
Qingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
Shanghai Hanhong Scientific Co.,Ltd.
website:http://www.chemvia.com
Contact:+86-21-64541543,54280654,13918533501
Address:Jiachuan Road 245
Dongying J&M Chemical Co., Ltd,
Contact:546-8551108
Address:Room 1219, Zisheng Mansion, Zibo Road, Dongying, Shandong, China
Doi:10.1039/jr9530003435
(1953)Doi:10.1107/S0567740882002532
(1982)Doi:10.1039/c19680001319
(1968)Doi:10.1016/j.tetasy.2004.11.069
(2005)Doi:10.1039/a802430h
(1998)Doi:10.1080/07328319808003475
(1998)